AzTrials
AzTrials

Cruciate Ligament RuptureNCT04592367

Reconstruction of the Anterior Cruciate Ligament(ACL-R) in the 30+-Year Old Assessed by Patient Reported Outcome Measures(PRO) Using the Nationwide Danish Knee Ligament Reconstruction Registry

An observational study of Cruciate Ligament Rupture, run by Region Zealand at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to evaluate the efficacy of primary ACL-R in patients 30 years of age or older using PRO. The PRO used are Knee Osteoarthritis Outcome Score(KOOS) and Tegner score. Read more about this study

Who is it for?
Any age
Conditions the study is for
Cruciate Ligament Rupture
What is being tested?
Patient age at time of procedure of reconstruction of ACL
Type of treatment
Surgery or procedure
How many people
30,487 participants
Where
1 siteDenmark
Study dates
1 Jan 2005to 31 Dec 2018
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: The study population is the entire Danish population. The completeness of registry, the epidemiology of ACL-rupture and ACL-R decides the composition of the cohort.

Who may be able to join

  • Patients receiving primary reconstruction of the ACL in the period 1st of January 2005 to 31st of December 2018

Who cannot join

  • Multi Ligament Surgery
  • Revision surgery of ACL

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Department of Orthopedic Surgery

    Køge, Region Zeland, 4600

Other trials in Denmark

About this study

Official title: Rekonstruktion af Forreste korsbånd Hos +30-årige Vurderet Ved Patient Reported Outcome Measures(PRO)

The purpose of the study is to evaluate the efficacy of primary ACL-R in patients 30 years of age or older using PRO. The PRO used are Knee Osteoarthritis Outcome Score(KOOS) and Tegner score. The Danish Knee Ligament Reconstruction Registry has data including more than 31,000 primary ACL-R performed in the period from 2005 to 2018, of which approximately a little less than 40% are performed in patients 30 years or older.

Traditionally, ACL-R has been used for the active, younger patients with the purpose of returning to their pre-injury level of activity. The increasing activity level and the desire to stay active among some patients in their fourth decade, and later, possibly increases the demands of the reconstructed ACL in this group. The aim is to investigate the PRO in this group of patients and compare them with the PRO of patients younger than 30 years of age. The study may help orthopedic surgeons counselling patients 30 years of age or older when deciding to perform an ACL-R.

The study's hypothesis is, that the overall benefit from ACL-R is equal but the patients 30 years of age or older has a worse baseline and as an implication of that worse PRO one year after the ACL-R.

Read the detailed description

Quality Assurance Plan: Clinical data reported by orthopedic surgeons at public and private hospitals, while patients undergoing ACL-R report PRO.

Source Data Verification with the Danish National Central Person Registry. Degree of completeness compared to Central Person Registry is approximately 85%.

Data dictionary provided by the data manager at RKKP - "Regionernes Kliniske Kvalitetudviklingsprogram" - Regional Clinical Quality Development Program. Patients are recruited when the ACL-R is performed, and approximately 35% report PRO 1 year after surgery. Data collection, data management and the extract from the Danish Knee Ligament Reconstruction Registry is performed by the Regional Clinical Quality Development Program. Data analysis done with support from statistician from "Region Sjælland" - Region Zealand. Sample Size Assessment not done. The cohort size is the largest we can get from the registry. The estimated number of patients 30 years of age or older with complete PROs is 2,600 men and 1,600 women. This estimation is based on the numbers from the annual report of 2019 from the Danish Knee Ligament Reconstruction Register, which states that 7,368 men and 4,656 women 30 years of age or older has undergone the procedure from 2005-2018. We expect that they report PROs as frequently as the entire cohort, which is approximately 35%. Patients with missing data will be described in table 3 and not used in table 2.

The study will present five tables.

Flowchart: Cohort size, excluded patients, patients with missing values, patients in each age group

Table 1: Descriptive statistics of the cohort with reported PRO stratified in three strata (0-14 years of age, 15-29 years of age or 30 years of age or older) with information about gender, age, previous surgery in the knee, activity at time of injury, operational technique and cartilage and meniscal status.

Table 2: Unpaired t-test if data shows normal distribution, otherwise Mann-Whitney, by change in KOOS from before surgery to one year after surgery, overall KOOS one year after surgery, Tegner one year after surgery, and Tegner from preoperatively to one year after surgery

Table 3: Descriptive statistics of population lost during follow-up

Table 4: Multivariate analysis for primary outcome

Sampling Method: Consecutive patients. Patients are enrolled into the registry when the ACL-R is performed. The completeness of registry depends on physicians' reporting of pre-, intra- and postoperative findings and patients' reporting of PROs.

Being tested
Patient age at time of procedure of reconstruction of ACL
Keywords
ACL,, PRO, PROM, age

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patient age at time of procedure of reconstruction of ACLProcedure or surgery

    Primary reconstruction of ACL with no other concomitant ligament reconstructions. Treatment of cartilage og meniscal injury may be a part of the procedure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in KOOS

    Measured: From before surgery, but after injury, to one year after surgery

Secondary outcomes (3)
  1. Total KOOS

    Measured: One year after surgery

  2. Total Tegner score

    Measured: One year after surgery

  3. Change in Tegner score

    Measured: From before surgery, but after injury, to one year after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Oct 2020
  2. Study start1 Jan 2005
  3. Primary completion31 Dec 2018
  4. Study completion31 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30,487 participants (actual)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT04592367
Sponsor's protocol ID
PRO-4ACL
Status last verified
Oct 2020
First submitted
12 Oct 2020
Last updated
19 Oct 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cruciate Ligament Rupture, run by Region Zealand at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in KOOS (time frame: From before surgery, but after injury, to one year after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in